AstraZeneca PLC

Pharmaceuticals & Biotechnology • Cambridge, United Kingdom

AstraZeneca PLC is a British-Swedish global biopharmaceutical company formed in 1999 through the merger of Sweden's Astra AB and the UK's Zeneca Group PLC. Headquartered in Cambridge, United Kingdom, the company focuses on the discovery, development and commercialisation of prescription medicines across major therapeutic areas including oncology, rare diseases, cardiovascular, renal and metabolic diseases, and respiratory and immunology. AstraZeneca's medicines are sold in more than 125 countries, supported by a global research and development network spanning Europe, North America and Asia. The company reported approximately 96,100 employees worldwide at 31 December 2025 and generated $58.7 billion in revenue during 2025.

Official Website

Quick Facts

Founded 1999
Industry Pharmaceuticals & Biotechnology
Headquarters Cambridge, United Kingdom
Country United Kingdom
State / Region England
Company Size 96,100 employees
Ownership Publicly Owned
Website www.astrazeneca.com

Powered by
►
Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.
None
►
Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.
None
►
Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.
None
►
Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.
None
Powered by